Eupraxia Pharmaceuticals Inc. (EPRX) vs InflaRx N.V. (IFRX)
A side-by-side comparison of Eupraxia Pharmaceuticals Inc. and InflaRx N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EPRX
Eupraxia Pharmaceuticals Inc.
$8.00HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
IFRX
InflaRx N.V.
$1.63HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — EPRX vs IFRX
growth of $100 · dividends reinvested · last 2yEPRX +162.7% (+62.1%/yr)IFRX +8.4% (+4.1%/yr)EPRX compounded faster over this window
EPRX IFRX
EPRX vs IFRX: by the numbers
- •EPRX is the larger company ($268M vs $240M market cap).
- •Both run net losses; EPRX's is the smaller (0.00% vs -155582.08% net margin).
Metrics side by side
Valuation
| Metric | EPRX | IFRX |
|---|---|---|
| P/B ratio | 2.64 | 1.44 |
Profitability
| Metric | EPRX | IFRX |
|---|---|---|
| Gross margin | 0.00% | -24677.94% |
| Operating margin | 0.00% | -164525.50% |
| Net margin | 0.00% | -155582.08% |
| ROE | -38.33% | -27.27% |
| ROIC | -43.56% | -25.38% |
Growth (annualized)
| Metric | EPRX | IFRX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -7.34% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.